AKT1 and neoplasm: Decreased phospho-Akt level and increased acetylated histone H3 level in tumor tissues treated with butyrate and LY294002 indicating NSCLC xenografts can be sensitized to undergo apoptosis with combined treatment with HDACI and PI3K/Akt pathway inhibitors.